Academic Journal

48MO SQZ-PBMC-HPV-101: Preliminary results of a first-in-human, dose-escalation study of a cell-based vaccine in HLA A*02+ patients with recurrent, locally advanced, or metastatic HPV16+ solid tumors

التفاصيل البيبلوغرافية
العنوان: 48MO SQZ-PBMC-HPV-101: Preliminary results of a first-in-human, dose-escalation study of a cell-based vaccine in HLA A*02+ patients with recurrent, locally advanced, or metastatic HPV16+ solid tumors
المؤلفون: Park, J-C., Baranda, J.C., Mita, M.M., Iams, W.T., Gordon, M.S., Taylor, M., Dhani, N., Loughhead, S.M., Ji, R-R., Zwirtes, R.F., Kornacker, M., Rosen, O., Bernstein, H., Jimeno, A.
المصدر: Annals of Oncology ; volume 32, page S1393 ; ISSN 0923-7534
بيانات النشر: Elsevier BV
سنة النشر: 2021
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.annonc.2021.10.065
الاتاحة: http://dx.doi.org/10.1016/j.annonc.2021.10.065
https://api.elsevier.com/content/article/PII:S0923753421046019?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0923753421046019?httpAccept=text/plain
Rights: https://www.elsevier.com/tdm/userlicense/1.0/ ; http://www.elsevier.com/open-access/userlicense/1.0/
رقم الانضمام: edsbas.9C75E5C1
قاعدة البيانات: BASE
الوصف
DOI:10.1016/j.annonc.2021.10.065